Related Experiment Video
Updated: Jun 12, 2026
04:30
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Stent thrombosis--risk assessment and prevention
Zuzana Motovska1, Jiri Knot, Petr Widimsky
1Third Medical Faculty, Charles University and University Hospital, Kralovske Vinohrady, Prague, Czech Republic. zuzana.motovska@iex.cz
Cardiovascular Therapeutics
|June 18, 2010
Summary
Stent thrombosis is a serious complication of percutaneous coronary intervention. This review covers stent thrombosis incidence, risk factors, and strategies to reduce its occurrence.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
Background:
- Percutaneous coronary intervention (PCI) with stenting is a primary treatment for coronary artery disease.
- Stents improve revascularization effectiveness, safety, and applicability in complex cases.
- Despite benefits, stent thrombosis remains a critical, life-threatening complication.
Purpose of the Study:
- To summarize current knowledge on stent thrombosis.
- To review the incidence, histopathology, and risk factors of stent thrombosis.
- To outline future strategies for preventing stent thrombosis.
Main Methods:
- Literature review and synthesis of existing data on stent thrombosis.
- Analysis of histopathological findings related to stent thrombosis.
- Identification and categorization of risk factors for stent thrombosis.
Main Results:
- Stent thrombosis is a rare but severe complication associated with both bare-metal and drug-eluting stents.
- Key risk factors include patient-related, stent-related, and procedure-related elements.
- Understanding histopathology is crucial for identifying thrombosis mechanisms.
Conclusions:
- Stenting is a cornerstone of coronary revascularization, but stent thrombosis necessitates ongoing research.
- Further research is needed to develop improved preventative strategies and reduce stent thrombosis incidence.
- Optimizing antiplatelet therapy and stent design are key future directions.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...